Brukinsa for Follicular Lymphoma User Reviews
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Follicular Lymphoma
Care guides
More about Brukinsa (zanubrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (44)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
"I am being treated for a recurrence of Non-Hodgkin's B-cell lymphoma (not one of the conditions above) after having chemo and immunotherapy some 7 years ago. After some 5 months of taking Brukinsa, my red blood cell count has improved significantly and continues to improve. My only discernible side effects are a reasonable increase in bleeding when shaving, although my blood seems to clot reasonably well, but my facial skin (and on my head) seems to have 'breakouts' which take much longer to heal, particularly when shaving. Dosage is 2 tablets of 80 mg each, twice daily. Obviously easy to use."